FRANKLIN RESOURCES INC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 165 filers reported holding NEKTAR THERAPEUTICS in Q4 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$20,716
+2.8%
34,781
-0.8%
0.00%
Q2 2023$20,161
-21.0%
35,051
-3.4%
0.00%
Q1 2023$25,514
-70.5%
36,297
-5.0%
0.00%
Q4 2022$86,366
-48.6%
38,215
-27.5%
0.00%
Q3 2022$168,000
+194.7%
52,720
+395.6%
0.00%
Q1 2022$57,000
-74.1%
10,638
-34.6%
0.00%
Q4 2021$220,000
+2.3%
16,272
+36.0%
0.00%
Q3 2021$215,000
-99.7%
11,964
-98.9%
0.00%
-100.0%
Q3 2018$67,830,000
+44.8%
1,112,700
+16.0%
0.03%
+41.7%
Q2 2018$46,843,000
-32.7%
959,300
+46.4%
0.02%
-31.4%
Q1 2018$69,643,000
+342.3%
655,400
-49.8%
0.04%
+400.0%
Q3 2014$15,747,000
-59.6%
1,304,619
-57.0%
0.01%
-58.8%
Q2 2014$38,930,000
+5.5%
3,036,700
-0.2%
0.02%0.0%
Q1 2014$36,892,000
+42.3%
3,043,900
+33.3%
0.02%
+30.8%
Q4 2013$25,917,000
+29.7%
2,283,434
+19.4%
0.01%
+18.2%
Q3 2013$19,978,000
+39.2%
1,911,834
+53.9%
0.01%
+37.5%
Q2 2013$14,352,0001,242,6000.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2014
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders